Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 2205-2210

  Wu, Zhichao ^a   Wang, Guangzhi ^a   Xu, Shaoqian ^a   Li, Yang ^a   Tian, Yu ^a   Niu, Hongshuang ^a   Yuan, Fei ^a   Zhou, Fenggang ^a   Hao, Zhen ^a   Zheng, Yongri ^a   Li, Qingsong ^a   Wang, Jianjiao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

ADAM17; Glioma; Tetrandrine

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TETRANDRINE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADAM PROTEINS; ANTINEOPLASTIC AGENTS; BENZYLISOQUINOLINES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GLIOMA; HUMANS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84899068917     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1293-y     Document Type: Article

References (24)

1. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2004-2007. Neuro Oncol. 2012;14:5v1-49.
2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn M, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459-66.
3. Bonavia R, Inda M, Cavenee WK, Furnari FB. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 2011;71:4055-60.
4. Kesari S. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments. Semin Oncol. 2011;38:S2-10.
5. Black RA. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol. 2002;34:1-5.
6. Primakoff P, Myles DG. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 2000;16:83-7.
7. Ding X, Yang LY, Huang GW, Wang W, Lu WQ. ADAM17 mRNA expression and pathological features of hepatocellular carcinoma. World J Gastroenterol. 2004;10:2735-9.
8. Wildeboer D, Naus S, Amy Sang QX, Bartsch JW, Pagenstecher A. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J Neuropathol Exp Neurol. 2006;65:516-27.
9. Tsatas D, Kanagasundaram V, Kaye A, Novak U. EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J Clin Neurosci. 2002;9:282-8.
10. Zheng X, Jiang F, Katakowski M, Kalkanis SN, Hong X, et al. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci. 2007;98:674-84.
11. Lal A, Glazer CA, Martinson HM, Friedman HS, Archer GE, et al. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res. 2002;62:3335-9.
12. Banks DE, Cheng YH, Weber SL, Ma JK. Strategies for the treatment of pneumoconiosis. Occup Med. 1993;8:205-32.
13. Chen Y, Chen JC, Tseng SH. Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int J Cancer. 2009;124:2260-9.
14. Chang KH, Chen ML, Chen HC, Huang YW, Wu TY, et al. Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine. Neoplasma. 1999;46:96-200.
15. Imoto K, Takemura H, Kwan CY, Sakano S, Kaneko M, et al. Inhibitory effects of tetrandrine and hernandezine on Ca21 mobilization in rat glioma C6 cells. Res Commun Mol Pathol Pharmacol. 1997;95:129-46.
16. Takemura H, Imoto K, Ohshika H, Kwan CY. Tetrandrine as a calcium antagonist. Clin Exp Pharmacol Physiol. 1996;23:751-3.
17. Ransom CB, Liu X, Sontheimer H. BK channels in human glioma cells have enhanced calcium sensitivity. Glia. 2002;38:281-91.
18. Du JH, Zhang HD, Ma ZJ, Ji KM. Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemother Pharmacol. 2010;65:895-902.
19. Cheng KH, Chen ML, Chen HC, Huang YW, Wu TY, et al. Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine. Neoplasma. 1999;46:96-200.
20. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature. 1984;309:418-25.
21. Kenny PA. Three-dimensional extracellular matrix culture models of EGFR signalling and drug response. Biochem Soc Trans. 2007;35:665-8.
22. Kenny PA. TACE: a new target in epidermal growth factor receptor dependent tumors. Differentiation. 2007;75:800-8.
23. Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene. 2000;19:6550-665.
24. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol. 2004;164:769-79.